latest news releases from the newsroom
Flint Telecom Group, Inc.
Semotus Solutions Continues Aggressive Marketing Campaign With NetIQ Conference
LOS GATOS, Calif., May 17, 2005 (PRIMEZONE) -- Semotus Solutions (AMEX:DLK), a leading provider of wireless communication and data access solutions for enterprise applications, will be exhibiting its product, IQLinkXS as a Silver Sponsor at the NetIQ Global Users Conference NetConnect, May 16 - 18, 2005, at the Royal Pacific Resort in Orlando, Florida. This will be the third consecutive year for Semotus exhibiting at the NetConnect Users Conference and the third of many events in an aggressive tradeshow campaign for 2005.
Intelligent Results and Ontario Systems Announce Partnership
BELLEVUE, Wash., May 17, 2005 (PRIMEZONE) -- Intelligent Results, a provider of customer analytics solutions, announced a partnership with Ontario Systems, a provider of receivables management information systems. Ontario Systems' customers can access leading-edge predictive scores to significantly improve collections and recovery operations. These scores use information stored in Ontario Systems' software to increase dollars recovered from delinquent and post-charge-off accounts.
Innovative Communications Technologies, Inc.
Innovative Reduces Expenses for Transportation and Distribution Businesses
SEATTLE, May 17, 2005 (PRIMEZONE) -- The transportation industry is discovering the benefits of using Innovative Communications Technologies' (Pink Sheets:ICTN) GPTN (Global Private Telecommunications Network) and Private800 products. Two of ICT's most recent business customers in this sector taking advantage of the typical 50% cost savings are The Peterson Company, Auburn, WA, a Northwest and national distributor of fine imported and domestic foods and Puget Sound Freight Lines, Seattle, WA, a regional and national truckload carrier of general freight commodities and bulk wood residuals.
Dow Jones Indexes
Dow Jones Indexes to Launch Index For Kuwait
NEW YORK and KUWAIT CITY, May 17, 2005 (PRIMEZONE) -- Dow Jones Indexes, a leading global index provider, today announced the launch of Dow Jones Kuwait Index, a composite equity index that will track the performance of the Kuwait stock market starting May 23, 2005. The index has been licensed to Industrial & Financial Investments Co. (IFIC) -- one of the leading investment firms in Kuwait -- to be used as the basis for index funds and index-related products.
Vodafone Sverige AB
Vodafone Sverige AB: Major Price Reduction on Mobile Calls Abroad
STOCKHOLM, Sweden, May 17, 2005 (PRIMEZONE) -- Under the slogan "Med Vodafone ar utomlands som hemma" Vodafone Sweden will announce several new services which will simplify and bring better value to Vodafone customers when roaming. The first service to be launched is Vodafone Passport that allow Vodafone Sweden's mobile customers travelling abroad to call home at Swedish prices when using Vodafone's network. The only surcharge is the connection fee of just SEK 9.95 per call.
Epigenomics AG Validates DNA Methylation Test as Predictor of Disease Recurrence in Breast Cancer Patients
BERLIN, Germany, May 17, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), today revealed data confirming that its proprietary DNA methylation markers are closely correlated with disease recurrence and prediction of therapy response in early breast cancer. Specific DNA methylation markers, including PITX2, will be incorporated into a test that will provide physicians with clinically relevant information that may spare approximately half of estrogen-dependent, node-negative breast cancer patients from going through the discomfort and side effects of chemotherapy. Currently, combined chemotherapy and endocrine therapy with drugs such as Tamoxifen is recommended as the treatment of choice for most breast cancer patients to prevent the disease from returning. However, a large proportion of patients treated with endocrine therapy alone have an excellent prognosis after 10 years and therefore do not need the additional chemotherapy. The data from the study which was presented at the 41st Annual Meeting of the American Society of Clinical Oncology (May 14-17, Orlando, Florida, USA) validate the role of the DNA methylation markers in identifying this group of patients. In addition, data were published in the journal Cancer Research which describe the identification of markers for tamoxifen response in advanced breast cancer, further underlining the importance of DNA methylation for this disease.